Clinical Trial Update: Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes Phase 2/Phase 3 testing of resveratrol for overweight adolescents with NAFLD and insulin resistance. The study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Manitoba | Conditions: NAFLD, TYPE 2 DIABETES | Phase 2, Phase 3 | Status: COMPLETED